Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$11.79 - $15.97 $40,333 - $54,633
-3,421 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$9.31 - $21.24 $33,516 - $76,464
-3,600 Reduced 51.27%
3,421 $46,000
Q4 2019

Feb 06, 2020

BUY
$13.91 - $21.48 $48,991 - $75,652
3,522 Added 100.66%
7,021 $141,000
Q4 2019

Feb 04, 2020

BUY
$13.91 - $21.48 $1,905 - $2,942
137 Added 4.07%
3,499 $63,000
Q3 2019

Nov 12, 2019

BUY
$15.84 - $30.01 $53,254 - $100,893
3,362 New
3,362 $54,000
Q3 2018

Nov 01, 2018

SELL
$8.1 - $13.6 $766,260 - $1.29 Million
-94,600 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$11.2 - $15.0 $1.06 Million - $1.42 Million
94,600 New
94,600 $1.08 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $277M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.